Milestone strengthens executive management team
This article was originally published in Scrip
Milestone Biosciences, a private US speciality biotechnology company focused on in-licensing and the commercialisation of oncology products, has appointed Eric Loukas chief executive officer. Current president, CEO and co-founder, Frank Jacobucci, will become president and chief operating officer. Mr Loukas has more than 21 years' industry experience; he was previously executive vice-president, chief operating officer, general counsel and corporate secretary at MGI Pharma.